What is GLSI's current P/B?

Greenwich LifeSciences, Inc.'s current P/B is 64.6, which is historically pricey relative to its 10-year historical range.

What is the 10-year average P/B for GLSI?

The approximate 10-year median P/B for GLSI is 17.4. The current reading of 64.6 is historically pricey.

Greenwich LifeSciences, Inc.GLSI

$23.38-0.61 (-2.54%)

NASDAQHealthcare24:00 UTC

Earnings & Price

Price EPS (TTM)P/E ratio PEG

Book & Enterprise

P/B EV/EBITDA

Dividend

Dividend Yield Payout Ratio Div / Share

Cash & Leverage

FCF Yield Net Debt / EBITDA

How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.

FormulaPrice / Book Value Per Share

Full guide

P/B History

Historically priceyAbove avgAround avgBelow avgHistorically cheap

No data available

How to read this chart

Most useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.

Key caveats

Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.

Is GLSI P/B High or Low Right Now?

Greenwich LifeSciences, Inc.'s P/B is currently 64.6, which is historically pricey relative to its 10-year historical range. The 10-year median P/B for GLSI is approximately 17.4. See all GLSI valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.